McDonagh TA, Metra M, Adamo M et al (2021) 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J 42(36):3599–3726

Article  CAS  PubMed  Google Scholar 

GBD 2017 Disease and Injury Incidence and Prevalence Collaborators (2018) Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet 392(10159):1789–1858

Lindsey ML, Hall ME, Harmancey R et al (2016) Adapting extracellular matrix proteomics for clinical studies on cardiac remodeling post-myocardial infarction. Clin Proteomics 13:19

Article  PubMed  PubMed Central  Google Scholar 

Ibanez B, James S, Agewall S et al (2018) 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: the task force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J 39(2):119–177

Article  PubMed  Google Scholar 

Cokkinos DV, Belogianneas C (2016) Left ventricular remodelling: a problem in search of solutions. Eur Cardiol 11(1):29–35

Article  PubMed  PubMed Central  Google Scholar 

Weir RA, McMurray JJ, Velazquez EJ (2006) Epidemiology of heart failure and left ventricular systolic dysfunction after acute myocardial infarction: prevalence, clinical characteristics, and prognostic importance. Am J Cardiol 97(10a):13f–25f

Article  PubMed  Google Scholar 

Kelly DJ, Gershlick T, Witzenbichler B et al (2011) Incidence and predictors of heart failure following percutaneous coronary intervention in ST-segment elevation myocardial infarction: the HORIZONS-AMI trial. Am Heart J 162(4):663–670

Article  PubMed  Google Scholar 

Konstam MA, Kramer DG, Patel AR et al (2011) Left ventricular remodeling in heart failure: current concepts in clinical significance and assessment. JACC Cardiovasc Imaging 4(1):98–108

Article  PubMed  Google Scholar 

Chen X-Y, He Y, Chen J-Y (2023) Pharmacological effects and mechanisms of Gastrodia elata and its active ingredients in the treatment of cardiovascular diseases. Tradit Med Res 8:49–54

Article  Google Scholar 

Chang Y, Wei W (2015) Angiotensin II in inflammation, immunity and rheumatoid arthritis. Clin Exp Immunol 179(2):137–145

Article  CAS  PubMed  PubMed Central  Google Scholar 

Marchesi C, Paradis P, Schiffrin EL (2008) Role of the renin-angiotensin system in vascular inflammation. Trends Pharmacol Sci 29(7):367–374

Article  CAS  PubMed  Google Scholar 

Fung ML (2014) The role of local renin-angiotensin system in arterial chemoreceptors in sleep-breathing disorders. Front Physiol 5:336

Article  PubMed  PubMed Central  Google Scholar 

Gu Y, Ding Y, Zhang X et al (2022) Secreted frizzled-related protein 3 alleviated cardiac remodeling induced by angiotensin II via inhibiting oxidative stress and apoptosis in mice. Eur J Pharmacol 934:175303

Article  CAS  PubMed  Google Scholar 

Gu Y, Zhang S, Chen X et al (2022) LongShengZhi alleviated cardiac remodeling via upregulation microRNA-150-5p with matrix metalloproteinase 14 as the target. J Ethnopharmacol 291:115156

Article  CAS  PubMed  Google Scholar 

Yalta K, Yilmaz MB, Yalta T et al (2020) Late versus early myocardial remodeling after acute myocardial infarction: a comparative review on mechanistic insights and clinical implications. J Cardiovasc Pharmacol Ther 25(1):15–26

Article  PubMed  Google Scholar 

Zaliaduonyte-Peksiene D, Simonyte S, Lesauskaite V et al (2014) Left ventricular remodelling after acute myocardial infarction: impact of clinical, echocardiographic parameters and polymorphism of angiotensinogen gene. J Renin Angiotensin Aldosterone Syst 15(3):286–293

Article  CAS  PubMed  Google Scholar 

Gu Y, Hu X, Ge PB et al (2021) CTRP1 aggravates cardiac dysfunction post myocardial infarction by modulating TLR4 in macrophages. Front Immunol 12:635267

Article  CAS  PubMed  PubMed Central  Google Scholar 

Westman PC, Lipinski MJ, Luger D et al (2016) Inflammation as a driver of adverse left ventricular remodeling after acute myocardial infarction. J Am Coll Cardiol 67(17):2050–2060

Article  PubMed  Google Scholar 

Van Linthout S, Tschöpe C (2017) Inflammation - cause or consequence of heart failure or both?. Curr Heart Fail Rep 14(4):251–265

Article  PubMed  PubMed Central  Google Scholar 

Wu L, Gao L, Zhang D et al (2018) C1QTNF1 attenuates angiotensin II-induced cardiac hypertrophy via activation of the AMPKa pathway. Free Radic Biol Med 121:215–230

Article  CAS  PubMed  Google Scholar 

de Araújo AA, Varela H, de Medeiros CA et al (2015) Azilsartan reduced TNF-α and IL-1β levels, increased IL-10 levels and upregulated VEGF, FGF, KGF, and TGF-α in an oral mucositis model. PLoS ONE 10(2):e0116799

Article  PubMed  PubMed Central  Google Scholar 

Kim KY, Kim HY, Kim JH et al (2006) Tumor necrosis factor-alpha and interleukin-1beta increases CTRP1 expression in adipose tissue. FEBS Lett 580(16):3953–3960

Article  CAS  PubMed  Google Scholar 

Gu Y, Zhang X, Zhang XW et al (2022) Correlation between serum Level of C1q/TNF-related protein 1 and prognosis of patients with acute ST segment elevation myocardial infarction. Mol Cardiol China 22(1):4427–4431

Google Scholar